Publications by authors named "Matthew McCourt"

Claim this Profile
A
An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression.
Richard C A Sainson, Anil K Thotakura, Miha Kosmac, Gwenoline Borhis, Nahida Parveen, Matthew McCourt

Cancer Immunol Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
Nadine D Arnold, Josephine A Pickworth, Laura E West, Sarah Dawson, Joana A Carvalho, Matthew McCourt

Nat Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.
Suzanne I S Mosely, John E Prime, Richard C A Sainson, Jens-Oliver Koopmann, Dennis Y Q Wang, Matthew McCourt

Cancer Immunol Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody.
Ross Stewart, Michelle Morrow, Scott A Hammond, Kathy Mulgrew, Danielle Marcus, Matthew McCourt

Cancer Immunol Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.
Nadia Luheshi, Gareth Davies, Edmund Poon, Kimberley Wiggins, Matthew McCourt

Eur J Immunol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved drug-like properties of therapeutic proteins by directed evolution.
Andrew Buchanan, Franco Ferraro, Steven Rust, Sudharsan Sridharan, Ruth Franks, Matthew McCourt

Protein Eng Des Sel· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
Christian Grütter, Trevor Wilkinson, Richard Turner, Sadhana Podichetty, Donna Finch, Matthew McCourt

Proc Natl Acad Sci U S A· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.
Ling Yu, Wayne A Border, Ian Anderson, Matthew McCourt, Yufeng Huang

Kidney Int· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis